Advanced Therapies Week 2022, Miami, Florida. Book Today

Autolus Therapeutics to Receive an Investment of Up to $250 million to Develop Obe-Cel CD19 CAR-T Therapeutic Candidate

Autolus Therapeutics to Receive an Investment of Up to $250 million to Develop Obe-Cel CD19 CAR-T Therapeutic Candidate

8 November 2021
Autolus Therapeutics to Receive an Investment of Up to $250 million to Develop Obe-Cel CD19 CAR-T Therapeutic Candidate
Read More
Recent Stories
EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio
1 December 2021
EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio
News
Autolus Therapeutics to Receive an Investment of Up to $250 million to Develop Obe-Cel CD19 CAR-T Therapeutic Candidate
8 November 2021
Autolus Therapeutics to Receive an Investment of Up to $250 million to Develop Obe-Cel CD19 CAR-T Therapeutic Candidate
News
FDA Delays PDUFA Date for BCMA CAR-T Therapy, Cilta-Cel, Until February 2022
4 November 2021
FDA Delays PDUFA Date for BCMA CAR-T Therapy, Cilta-Cel, Until February 2022
News
Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours
28 October 2021
Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours
News
POPULAR NEWS ITEMS
Image
1 December 2021

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

Image
26 November 2021

Top in Tech: Technology Demonstration Library

Image
23 November 2021

Advanced Therapies Investment Round-Up: Biotech on Cloud 9

Early Clinical Trial Results Suggest a Step Towards the First In Vivo Genome Editing Opportunity in Children
20 October 2021
Early Clinical Trial Results Suggest a Step Towards the First In Vivo Genome Editing Opportunity in Children
News
Strategic Collaboration Announced to Accelerate Automation for Cell and Gene Therapies
13 October 2021
Strategic Collaboration Announced to Accelerate Automation for Cell and Gene Therapies
News
Load More News
RECOMENDED TOPICS
Allogeneic
Cell Therapy
Regulatory & Standards
CAR-X
Finance & Investment
Cell-Based IO
Collaborations, Mergers & Acquisitions
Clinical Trials
Gene Editing
Gene Therapy
Automation & Digitisation
NKx
GMP
Scaling Up
Viral/Non-Viral Vectors
Skills, Talent & Development
Stem Cells
Tissue Engineering
Point of Care
Reimbursement
Uncategorized
POPULAR NEWS ITEMS
Image

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

Image

Top in Tech: Technology Demonstration Library

Image

Advanced Therapies Investment Round-Up: Biotech on Cloud 9